INSIGHTS ON DRUG DEVELOPMENT
-
Rapid Walkaway Solution For Assessing Viability In Cancer Organoids
Assess anti-cancer compounds' effects on organoid size and morphology with colorectal cancer organoids as well as discover automated imaging and viability assays to streamline drug screening and aid early identification.
-
LC-UV-Based Synthetic Peptide Impurity Tracking And Reporting
Explore a UPLC-UV method using Empower 3 Software to assess synthetic peptide purity. Learn how integrated tools streamline impurity tracking, data reporting, and compliance in peptide analysis workflows.
-
Using SEC For Reliable Biotherapeutic Peptide Analysis
Discover a breakthrough in analytical performance that delivers unmatched precision, faster results, and reduced waste. This innovation sets a new standard for sustainable, high-resolution analysis.
-
Why DSC Testing Is A Critical Step In Developing Biosimilar Drugs
Explore the importance of testing in the regulatory process and how tools like Differential Scanning Calorimetry (DSC) are helping to bring more biosimilars to patients in need.
-
Creating A Shigella Infection Model Using Organs-On-Chips4/9/2024
Learn how researchers have utilized Organs-on-Chips technology to test the infectivity of Shigella through several experimental approaches.
-
Key Metrics In Antibody Drug Development6/26/2025
Explore key techniques like DSC and Rheology to assess thermal stability and viscosity in antibody drug development. Gain practical insights to enhance biologic candidate selection, formulation, and delivery.
-
Top Challenges In Recombinant Protein Purification Process Development3/27/2024
Get insights from process developers working with recombinant proteins that cannot be purified with affinity chromatography.
-
Accelerating Drug Development For Inflammatory Bowel Disease With Organ-Chips3/25/2024
Marianne Kanellias unveils how Emulate's Organ-on-a-Chip technology is revolutionizing the field by enabling a more accurate and complex model of IBD pathogenesis.
-
How To Choose The Right CDMO For Your Pharmaceutical Project- Part One: Will They Deliver?4/17/2024
Choosing the right CDMO is crucial for the success of your pharmaceutical project. Learn how to strike the ideal balance between an organization's technical expertise, facilities, and efficiency.
DRUG DEVELOPMENT SOLUTIONS
-
Platform of automated, single-use systems for tangential flow filtration at multiple scales.
-
Nanoform’s GMP facility utilizes its award-winning Controlled Expansion of Supercritical Solutions (CESS®) technology for the manufacture of API nanoparticles to GMP standards.
-
The BioAccord™ LC-MS System with dedicated workflows for the Sartorius Ambr® 15 and small bioreactors enables process engineers to directly measure Product Quality Attributes (PQAs) and cell culture media.
-
Early identification of potential absorption risks is critical for rapid and efficient drug development. Lonza's PBPK modeling services are designed to de-risk your drug development program.
-
Explore a system that has revolutionized analytical science and delivers faster throughput, sharper resolution, and reliable data to accelerate discovery and elevate your lab’s performance.